Desmin modifications associate with amyloid-like oligomers deposition in heart failure

Cardiovascular Research

Volumn 102, Issue 1, 2014, Pages 24-34

  Agnetti, Giulio ^a,b   Halperin, Victoria L ^a   Kirk, Jonathan A ^a   Chakir, Khalid ^a   Guo, Yurong ^c   Lund, Linda ^a   Nicolini, Francesco ^d   Gherli, Tiziano ^d   Guarnieri, Carlo ^b   Caldarera, Claudio M ^b   Tomaselli, Gordon F ^a   Kass, David A ^a   Van Eyk, Jennifer E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

Amyloid; Desmin; Heart failure; Post translational modifications; Proteomics

Indexed keywords

6 BROMOINDIRUBIN 3 OXIME; AMYLOID; DESMIN; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; OLIGOMER; UNCLASSIFIED DRUG; GLYCOGEN SYNTHASE KINASE 3; PROTEIN AGGREGATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANINE MODEL; CARDIAC RESYNCHRONIZATION THERAPY; CONSENSUS SEQUENCE; CONTROLLED STUDY; DYSSYNCHRONOUS HEART FAILURE; HEART FAILURE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MECHANICAL STRESS; MONGREL DOG; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; ANIMAL; DOG; GENETICS; METABOLISM; MUTATION; PHOSPHORYLATION; PHYSIOLOGY; PROCEDURES; PROTEOMICS;

ANIMALS; CARDIAC RESYNCHRONIZATION THERAPY; DESMIN; DOGS; GLYCOGEN SYNTHASE KINASE 3; HEART FAILURE; MUTATION; PHOSPHORYLATION; PROTEIN AGGREGATES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS;

EID: 84896934439     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu003     Document Type: Article

References (45)

1. Diwan A, Dorn GW II. Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology (Bethesda) 2007;22:56-64.
2. Hoshijima M, Chien KR. Mixed signals in heart failure: cancer rules. J Clin Invest 2002;109: 849-855.
3. Kass DA. Rescuing a failing heart: putting on the squeeze. Nat Med 2009;15:24-25.
4. Hein S, Kostin S, Heling A, Maeno Y, Schaper J. The role of the cytoskeleton in heart failure. Cardiovasc Res 2000;45:273-278.
5. Lazarides E. Intermediate filaments as mechanical integrators of cellular space. Nature 1980;283:249-256.
6. Clemen CS, Herrmann H, Strelkov SV, Schroder R. Desminopathies: pathology and mechanisms. Acta Neuropathol 2013;125:47-75.
7. Agnetti G, Kaludercic N, Kane LA, Elliott ST, Guo Y, Chakir K et al. Modulation of mito-chondrial proteome and improvedmitochondrial functionbybiventricular pacingofdys-synchronous failing hearts. Circ Cardiovasc Genet 2010;3:78-87.
8. Agnetti G, Bezstarosti K, Dekkers DH, Verhoeven AJ, Giordano E, Guarnieri C et al. Proteomic profiling of endothelin-1-stimulated hypertrophic cardiomyocytes reveals the increase of four different desmin species and alpha-B-crystallin. Biochim Biophys Acta 2008;1784:1068-1076.
9. Corbett JM, Why HJ, Wheeler CH, Richardson PJ, Archard LC, Yacoub MH et al. Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional poly-acrylamide gel electrophoresis. Electrophoresis 1998;19:2031-2042.
10. Panagopoulou P, Davos CH, Milner DJ, Varela E, Cameron J, Mann DL et al. Desmin mediates TNF-alpha-induced aggregate formation and intercalated disk reorganization in heart failure. J Cell Biol 2008;181:761-775.
11. Diguet N, Mallat Y, Ladouce R, Clodic G, Prola A, Tritsch E et al. Muscle creatine kinase deficiency triggers both actin depolymerization and desmin disorganization by advanced glycation end products in dilated cardiomyopathy. J Biol Chem 2011;286:35007-35019.
12. Sanbe A, Osinska H, Villa C, Gulick J, Klevitsky R, Glabe CG et al. Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc Natl Acad Sci USA 2005;102:13592-13597.
13. Nelson R, Eisenberg D. Structural models of amyloid-like fibrils. Adv Protein Chem 2006; 73:235-282.
14. Wang X, Osinska H, Klevitsky R, Gerdes AM, Nieman M, Lorenz J et al. Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. Circ Res 2001;89:84-91.
15. Chakir K, Daya SK, Tunin RS, Helm RH, Byrne MJ, Dimaano VL et al. Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation 2008;117:1369-1377.
16. Sugden PH, Fuller SJ, Weiss SC, Clerk A. Glycogen synthase kinase3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol 2008;153 (Suppl 1):S137-S153.
17. Kane LA, Neverova I, Van Eyk JE. Subfractionation of heart tissue: the 'in sequence' myo-filament protein extraction of myocardial tissue. Methods Mol Biol 2007;357:87-90.
18. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997;18:2071-2077.
19. Knoll R, Kostin S, Klede S, Savvatis K, Klinge L, Stehle I et al. A common MLP (muscle LIM protein) variant is associated with cardiomyopathy. Circ Res 2010;106:695-704.
20. Sanbe A, Yamauchi J, Miyamoto Y, Fujiwara Y, Murabe M, Tanoue A. Interruption of CryAB-amyloid oligomer formation by HSP22. J Biol Chem 2007;282:555-563.
21. Herve R, Collin R, Pinchin HE, Secker T, Keevil CW. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions. J Microbiol Methods 2009;77:90-97.
22. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003;300:486-489.
23. Kinoshita E, Kinoshita-Kikuta E, Takiyama K, Koike T. Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol Cell Proteomics 2006;5:749-757.
24. Koitabashi N, Kass DA. Reverse remodeling in heart failure-mechanisms and therapeutic opportunities. Nat Rev Cardiol 2011;9:147-157.
25. Agnetti G, Husberg C, Van Eyk JE. Divide and conquer: the application of organelle pro-teomics to heart failure. Circ Res 2011;108:512-526.
26. Ma J, Lindquist S. Wild-type PrP and amutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci USA 2001;98: 14955-14960.
27. Roberts BE, Duennwald ML, Wang H, Chung C, Lopreiato NP, Sweeny EA et al. A syn-ergistic small-molecule combination directly eradicates diverse prion strain structures. Nat Chem Biol 2009;5:936-946.
28. 2+ activated protease specific for the intermediate-sized filament proteins vimentin and desmin. Eur J Cell Biol 1981;26:61-67.
29. Geisler N, Weber K. Phosphorylation of desmin in vitro inhibits formationofintermediate filaments; identification of three kinase A sitesinthe aminoterminal head domain. EMBO J 1988;7:15-20.
30. Rappaport L, Contard F, Samuel JL, Delcayre C, Marotte F, Tome Fet al. Storageofphos-phorylated desmin in a familial myopathy. FEBS Lett 1988;231:421-425.
31. Huang X, Li J, Foster D, Lemanski SL, Dube DK, Zhang C et al. Protein kinase C-mediated desmin phosphorylation is related to myofibril disarray in cardiomyopathic hamster heart. Exp Biol Med (Maywood) 2002;227:1039-1046.
32. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991;83:504-514.
33. Agnetti G, Halperin-Kuhns V, Guo Y, Sheng S, Fu Z, Nicolini F et al. Abstract 1809: novel human and canine desmin phosphorylations as potential regulators of oligomer formation and disease in heart failure. Circulation 2009;120:S559-c.
34. Houser SR, Margulies KB, Murphy AM, Spinale FG, Francis GS, Prabhu SD et al. Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res 2012;111:131-150.
35. Geisler N, Weber K. The amino acid sequence of chicken muscle desmin provides a common structural model for intermediate filament proteins. EMBO J 1982;1: 1649-1656.
36. 2+-activated proteinase specific for these intermediate filament proteins. Mol Cell Biol 1983;3: 1146-1156.
37. Hooper C, Killick R, Lovestone S. The GSK3 hypothesis of Alzheimer's disease. J Neurochem 2008;104:1433-1439.
38. Stefani M, Dobson CM. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med (Berl) 2003;81: 678-699.
39. Perng MD, Wen SF, van den Ijssel P, Prescott AR, Quinlan RA. Desmin aggregate formation by R120G alphaB-crystallin is caused by alteredfilament interactions and isdepend-ent upon network status in cells. Mol Biol Cell 2004;15:2335-2346.
40. Willis MS, Patterson C. Proteotoxicity and cardiac dysfunction- Alzheimer's disease of the heart? N Engl J Med 2013;368:455-464.
41. Gianni D, Li A, Tesco G, McKay KM, Moore J, Raygor Ket al. Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy. Circulation 2010;121: 1216-1226.
42. Mace LC, Yermalitskaya LV, Byrne JG, Petracek MR, Greelish JP, Hoff SJ et al. Abstract 16499: preamyloid oligomers are present in human atrium and are associated with postoperative atrial fibrillation. Circulation 124:A16499.
43. Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, Head E et al. Annular protofibrils areastructurally and functionally distinct typeofamyloid oligomer. J Biol Chem 2009;284: 4230-4237.
44. Kreplak L, Herrmann H, Aebi U. Tensile properties of single desmin intermediate filaments. Biophys J 2008;94:2790-2799.
45. Wolfe LS, Calabrese MF, Nath A, Blaho DV, Miranker AD, Xiong Y. Protein-induced photophysical changes to the amyloid indicator dye thioflavin T. Proc Natl Acad Sci USA 2010;107:16863-16868.